Description

Neogabin 150 (pregabalin) capsules 150 mg. №30

Ingredients

Each capsule contains 150 mg of pregabalin.

Dosage

The recommended dosage is as prescribed by a healthcare provider.

Indications

Neogabin 150 is indicated for the management of neuropathic pain, fibromyalgia, and as an adjunctive therapy for adults with partial onset seizures.

Contraindications

Do not use Neogabin 150 if allergic to pregabalin or any of the ingredients in the formulation.

Directions

Swallow the capsules whole with water, with or without food, as directed by a healthcare professional.

Scientific Evidence

Pregabalin, the active ingredient in Neogabin 150, exerts its effects by binding to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system. This mechanism reduces the release of excitatory neurotransmitters, thereby modulating pain signaling and providing relief from neuropathic pain.

Several clinical trials have demonstrated the efficacy of pregabalin in the management of neuropathic pain conditions such as diabetic neuropathy and postherpetic neuralgia. A study by Toth et al. (2014) showed significant pain reduction and improved quality of life in patients with diabetic neuropathy treated with pregabalin.

Additional Information

Neogabin 150 may cause dizziness and drowsiness. It is important to avoid driving or operating machinery until the individual response to the medication is known. Additionally, abrupt discontinuation of pregabalin may result in withdrawal symptoms, and dosage adjustments may be necessary in patients with renal impairment.

Consult a healthcare provider for personalized recommendations and to discuss the potential benefits and risks of using Neogabin 150 for your specific condition.